with
Shortwave Infrared (SWIR), ranging from 1000 to 2000 nm, penetrates biological tissues more deeply than visible and near-infrared light.
Shortwave Infrared provides rich, natural contrast information, such as variations in water and lipid content, offering valuable insights into tissue composition.
Enhance the efficiency and accuracy of lymph node grossing in your lab without changing any workflow.
A.I. powered real-time intraoperative Critical Structure Identification
Disclaimer: This device is not yet approved by the U.S. Food and Drug Administration (FDA). It is currently undergoing development and evaluation.
Disclaimer: This device is not yet approved by the U.S. Food and Drug Administration (FDA). It is currently undergoing development and evaluation.
We’re excited to unveil our exclusive Visionary Program, tailored for those who are eager to be at the forefront of innovation in pathology!
This program offers two distinct opportunities for our early partners to gain unique advantages with the InVision device.
Precision Surgical Interventions Program
Cision Vision receives the prestigious ARPA-H Award and wins up to $22.3 million dollars of government funding.
See press releases
See news coverage
Our first original article in the Journal of Clinical Pathology was published on 8/26/25. Our 104-patient study found that the use of our InVision imaging system detected 86.5% more lymph nodes than conventional methods and changed staging in 3.8% of cases.
We’re pleased to co-present with Algoscope at this year’s European Congress of Pathology annual meeting in Vienna, Austria.
We’re thrilled to share that Dr. Sophia Diaz from Johns Hopkins Medicine presented our groundbreaking technology at ACS Maryland!
Guided by insights from clinicians across multiple disciplines, we are committed to advancing cutting-edge scientific research and tackling unmet clinical needs.
“Innovation is not about tools but about reimagining how we save lives.”
Jeremy Li, CEO
